What is the equity of Imunon this year?
Imunon has equity of 13.39 M USD this year.
Imunon Equity 2024
Imunon Equity
13.39 M USD
Ticker
IMNN
ISIN
US15117N6022
WKN
A3DWEJ
In 2024, Imunon's equity was 13.39 M USD, a -54.36% increase from the 29.33 M USD equity in the previous year.
Imunon Aktienanalyse
What does Imunon do?
Imunon ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Imunon's Equity
Imunon's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Imunon's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Imunon's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Imunon's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Imunon’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Imunon stock
What was the equity of Imunon compared to the previous year?
The equity of Imunon has increased/decreased by -54.36% decreased compared to the previous year.
What impact does a high equity have on investors of Imunon?
A high equity is advantageous for investors of Imunon as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Imunon?
A low equity can be a risk for investors of Imunon, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Imunon affect the company?
An increase in equity of Imunon can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Imunon affect the company?
A reduction in equity of Imunon can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Imunon?
Some factors that can affect the equity of Imunon include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Imunon so important for investors?
The equity of Imunon is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Imunon take to change the equity?
To change equity, Imunon can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Imunon pay?
Over the past 12 months, Imunon paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Imunon is expected to pay a dividend of 0 USD.
What is the dividend yield of Imunon?
The current dividend yield of Imunon is .
When does Imunon pay dividends?
Imunon pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Imunon?
Imunon paid dividends every year for the past 0 years.
What is the dividend of Imunon?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Imunon located?
Imunon is assigned to the 'Health' sector.
Wann musste ich die Aktien von Imunon kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Imunon from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Imunon pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Imunon in the year 2023?
In the year 2023, Imunon distributed 0 USD as dividends.
In which currency does Imunon pay out the dividend?
The dividends of Imunon are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Imunon
Our stock analysis for Imunon Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Imunon Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.